title: Exhaled nitric oxide levels and airway responsiveness to adenosine 5'-monophosphate in subjects with nasal polyposis.
abstract: BACKGROUND
  It is widely appreciated that asthma is an inflammatory disease of the airways associated with airway hyperresponsiveness, and that nasal polyposis and asthma are related diseases. The objective of this study was to determine differences in exhaled nitric oxide (ENO) levels and airway responsiveness to adenosine 5'-monophosphate (AMP) between nonasthmatic patients with nasal polyposis and healthy controls.
  
  
  METHODS
  Twenty patients without asthma with nasal polyposis and 16 healthy control subjects were enrolled in the study. Participants were challenged with increasing concentrations of AMP and methacholine. ENO was measured with the single-exhalation method.
  
  
  RESULTS
  Bronchoconstriction in response to AMP was detected in 7 (35%) subjects with nasal polyposis. The geometric mean (95% CI) of ENO for subjects with nasal polyposis was 33.1 parts per billion (ppb) (24.0-45.7 ppb) compared with 12.3 ppb (8.5-18.2 ppb) for the healthy controls (p = 0.0002). ENO values were significantly higher in atopic than in nonatopic subjects with nasal polyposis [51.3 ppb (32.3-83.2 ppb) vs. 24.5 ppb (16.2-37.1 ppb), p = 0.02]. Nonatopic subjects with nasal polyposis also had higher concentrations of ENO than healthy control subjects (p = 0.016).
  
  
  CONCLUSIONS
  Inhaled AMP causes airway narrowing in a significantly higher proportion of nonasthmatic subjects with nasal polyposis than in healthy controls. Furthermore, increased concentrations of ENO are detected in atopic and nonatopic subjects with nasal polyposis. These results suggest that bronchial inflammation is present in nonasthmatic subjects with nasal polyposis.
authors.affiliation: Sección de Alergología, Hospital Universitario Dr. Peset, Valencia, Spain.
authors.forename: L
authors.initials: L
authors.lastname: Prieto
authors.forename: T
authors.initials: T
authors.lastname: Seijas
authors.forename: V
authors.initials: V
authors.lastname: Gutiérrez
authors.forename: S
authors.initials: S
authors.lastname: Uixera
authors.forename: L
authors.initials: L
authors.lastname: Bruno
authors.forename: R
authors.initials: R
authors.lastname: López
mesh_terms: D000249:Adenosine Monophosphate / Q000008:administration & dosage*; D000328:Adult; D016535:Bronchial Hyperreactivity / Q000378:metabolism; D001985:Bronchial Provocation Tests; D016084:Bronchoconstriction / Q000187:drug effects; D016085:Bronchoconstrictor Agents / Q000008:administration & dosage; D045853:Exhalation / Q000502:physiology*; D005260:Female; D005541:Forced Expiratory Volume / Q000187:drug effects; D006801:Humans; D008297:Male; D016210:Methacholine Chloride / Q000008:administration & dosage; D009298:Nasal Polyps / Q000378:metabolism*; D009569:Nitric Oxide / Q000378:metabolism*; D013223:Statistics as Topic
chemical_list: D016085:Bronchoconstrictor Agents; D016210:Methacholine Chloride; D009569:Nitric Oxide; D000249:Adenosine Monophosphate